Finance

Lists
TENX:NASDAQ
Tenax Therapeutics Inc
1,94 $
+0,78%
(+0,015) 1D
2 қаз., 14:00:38 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TENX...
Open
1,96 $
High
1,98 $
Low
1,92 $
Mkt. cap
72,79 млн
Avg. vol.
4,92 млн
Volume
1,29 млн
52-wk high
19,40 $
52-wk low
1,31 $
EPS
-1,47 $
Beta
0,92
Shares outstanding
37,42 млн
No. of employees
15
Open
1,96 $
High
1,98 $
Low
1,92 $
Mkt. cap
72,79 млн
Avg. vol.
4,92 млн
Volume
1,29 млн
52-wk high
19,40 $
52-wk low
1,31 $
EPS
-1,47 $
Beta
0,92
Shares outstanding
37,42 млн
No. of employees
15
News stories
From web sources and news partners
About Tenax Therapeutics Inc
CEOChris Giordano
Employees15
Founded1967
Headquarters-
Sector-
Websitetenaxthera.com
Analyst ratings
Based on 10 analysts giving stock ratings to TENX in the past 3 months
Buy
Buy
6
Hold
4
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for TENX in the last 3 months.
Highest
Current 1,94 $
35,00 $ (+1 699,49%)
Average
9,63 $ (+395,12%)
Lowest
4,00 $ (+105,66%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
14,00 $
+619,8%
09/15/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
35,00 $
+1 699,5%
09/09/2026
Angela Qian
Canaccord Genuity
Buy
Maintained
4,00 $
+105,7%
08/31/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
08/31/2026
Seamus Fernandez
Guggenheim
Hold
Downgraded
-
-
08/31/2026
Gautam Chukka
Chardan Capital
Hold
Downgraded
5,00 $
+157,1%
08/11/2026
David Risinger
Leerink Partners
Buy
Maintained
4,00 $
+105,7%
08/11/2026
Gaurav Maini
LifeSci Capital
Buy
Maintained
5,00 $
+157,1%
08/10/2026
Gavin Clark-Gartner
Evercore ISI
Hold
Downgraded
5,00 $
+157,1%
08/10/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
5,00 $
+157,1%
08/10/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
35,00 $
+1 699,5%
07/28/2026
Unknown Analyst
Chardan Capital
Buy
Initiated
27,00 $
+1 288,2%
06/22/2026
Unknown Analyst
Roth MKM
Buy
Maintained
30,00 $
+1 442,4%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10,33 млн
10,54 млн
11,54 млн
12,85 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,48 млн
5,91 млн
5,03 млн
5,93 млн
Operating expense
16,81 млн
16,45 млн
16,57 млн
18,78 млн
Total operating expenses
16,81 млн
16,45 млн
16,57 млн
18,78 млн
Operating income
-16,81 млн
-16,45 млн
-16,57 млн
-18,78 млн
Other non operating income
-15,00 мың
-9,00 мың
-4,00 мың
-
EBT including unusual items
-15,80 млн
-15,54 млн
-15,72 млн
-17,80 млн
EBT excluding unusual items
-15,80 млн
-15,54 млн
-15,72 млн
-17,80 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15,80 млн
-15,54 млн
-15,72 млн
-17,80 млн
Net profit margin
-
-
-
-
Earnings per share
-0,40
-0,38
-0,35
-0,35
Interest and investment income
1,02 млн
918,00 м.
861,00 м.
981,00 м.
Interest expense
-
-
-
-
Net interest expenses
1,02 млн
918,00 м.
861,00 м.
981,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары